Frequently Asked Questions
Common Questions About Using ICD-10 Code F18.921 for Inhalant use, unspecified with intoxication with delirium
What are the common symptoms of inhalant use with delirium?
Common symptoms include confusion, disorientation, dizziness, and altered mental status. Patients may also exhibit agitation and respiratory distress, necessitating immediate medical evaluation.
How is inhalant use treated in a clinical setting?
Treatment typically involves supportive care, monitoring vital signs, and addressing any respiratory issues. Benzodiazepines may be used for severe agitation, and education on the risks of inhalant use is crucial.
When should ICD-10 Code F18.921 be used?
This code should be used when a patient presents with symptoms of intoxication and delirium specifically related to inhalant use, ensuring accurate documentation and billing.
Can inhalant use lead to long-term effects?
Yes, chronic inhalant use can result in long-term neurological damage, cognitive impairment, and other serious health issues, highlighting the importance of early intervention and treatment.
